Heron Therapeutics reported $433K in Interest Income for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Alnylam Pharmaceuticals ALNY:US USD 14.08M 6.26M
Endo International ENDP:US USD 178K 31K
Esperion Therapeutics ESPR:US USD 900K 100K
Jazz Pharmaceuticals JAZZ:US USD 7.1M 3.6M
Nektar Therapeutics NKTR:US USD 3.13M 1.08M
Pacira PCRX:US USD 2.78M 1.55M
Sangamo BioSciences SGMO:US USD 3.68M 1.91M
Ultragenyx Pharmaceutical RARE:US USD 6.2M 2.72M
Veracyte VCYT:US USD 1.15M 575K
Vertex Pharmaceuticals VRTX:US USD 86M 39.8M